SEC Clinical Research — Pensacola, Florida

SEC Clinical Research is a clinical research site located in Pensacola, Florida, United States 32503.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

SEC Clinical Research has participated in 9 clinical trials with 7 currently active.

Therapeutic areas: Idiopathic Pulmonary Fibrosis, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.

Sponsors: Boehringer Ingelheim, BioNTech SE, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SEC Clinical Research?

SEC Clinical Research has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SEC Clinical Research conducted?

SEC Clinical Research has 9 clinical trials on record, with 7 currently active. Their work covers Idiopathic Pulmonary Fibrosis, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.

Is SEC Clinical Research accredited by Crixeo Health?

Yes — SEC Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about SEC Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.